Generation and Characterization of Recombinant Pseudorabies Virus Delivering African Swine Fever Virus CD2v and p54
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms25010335 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jianhui Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University Qishan C…. Hauptthemen laut MEDLINE: Herpesvirus 1, Suid, Pseudorabies, African Swine Fever Virus, African Swine Fever. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University-industry cooperation project of Fujian 793 Province of China, university–industry cooperation project of the Fujian 793 Province of China.
Abstract (Originalsprache)
African swine fever (ASF) leads to high mortality in domestic pigs and wild boar, and it is caused by the African swine fever virus (ASFV). Currently, no commercially available vaccine exists for its prevention in China. In this study, we engineered a pseudorabies recombinant virus (PRV) expressing ASFV CD2v and p54 proteins (PRV-∆TK-(CD2v)-∆gE-(p54)) using CRISPR/Cas9 and homologous recombination technology. PRV-∆TK-(CD2v)-∆gE-(p54) effectively delivers CD2v and p54, and it exhibits reduced virulence. Immunization with PRV-∆TK-(CD2v)-∆gE-(p54) neither induces pruritus nor causes systemic infection and inflammation. Furthermore, a double knockout of the TK and gE genes eliminates the depletion of T, B, and monocytes/macrophages in the blood caused by wild-type viral infection, decreases the proliferation of granulocytes to eliminate T-cell immunosuppression from granulocytes, and enhances the ability of the immune system against PRV infection. An overexpression of CD2v and p54 proteins does not alter the characteristics of PRV-∆TK/∆gE. Moreover, PRV-∆TK-(CD2v)-∆gE-(p54) successfully induces antibody production via intramuscular (IM) vaccination and confers effective protection for vaccinated mice upon challenge. Thus, PRV-∆TK-(CD2v)-∆gE-(p54) demonstrates good immunogenicity and safety, providing highly effective protection against PRV and ASFV. It potentially represents a suitable candidate for the development of a bivalent vaccine against both PRV and ASFV infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, College of Life Science, Fujian Normal University Qishan Campus, Fuzhou 350117, China.
- Institute of Animal Husbandry and Veterinary Medicine, Fujian Academy of Agricultural Sciences, Fuzhou 350117, China.
ORCID-Profile: Jianhui Wei, Chuancheng Liu, Qi Chen, Zhihua Feng
Förderung
- University-industry cooperation project of Fujian 793 Province of China
- university–industry cooperation project of the Fujian 793 Province of China
Zitieren
APA
Wei, J., Liu, C., He, X., Abbas, B., Chen, Q., Li, Z., & Feng, Z. (2023). Generation and Characterization of Recombinant Pseudorabies Virus Delivering African Swine Fever Virus CD2v and p54. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25010335
Vancouver
Wei J, Liu C, He X, Abbas B, Chen Q, Li Z, et al. Generation and Characterization of Recombinant Pseudorabies Virus Delivering African Swine Fever Virus CD2v and p54. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms25010335
BibTeX
@article{Wei2023,
author = {Wei, Jianhui and Liu, Chuancheng and He, Xinyan and Abbas, Bilal and Chen, Qi and Li, Zhaolong and Feng, Zhihua},
title = {Generation and Characterization of Recombinant Pseudorabies Virus Delivering African Swine Fever Virus CD2v and p54},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms25010335}
}
EUVIMED